The French public health service has recommended that those under the age of 30 be vaccinated with Pfizer against covid-19 instead of Moderna, whenever possible, as the latter carries a relatively higher risk of heart problems.
The Higher Health Authority (HAS), which provides health advice but does not have the authority to ban or authorize drugs and preparations, cited a “very rare” risk of developing myocarditis, based on recent vaccine data. of Moderna and in a French study published yesterday Monday.
“In the population under the age of 30, this risk appears to be about five times lower with Pfizer’s Comrinaty vaccine than with Moderna’s Spikevax,” HAS said in a recommendation released yesterday.
Authorities in other countries – including Canada, Finland and Sweden – have taken a more defensive stance against Spikevax amid concerns about young people having heart problems.
The European Medicines Agency (EMA) last month approved the Moderna vaccine to be given as a repeat dose to all adults over the age of 18, at least six months after the second dose.
EMA had earlier this year identified a possible link between myocarditis, a very rare inflammatory disease, and the Pfizer and Moderna covid-19 vaccines.
However, EMA had stressed that the benefits of these two vaccines outweigh the risks, echoing the views of US regulators and the World Health Organization.
For adults over the age of 30, HAS clearly recommends that they be immunized with the Moderna vaccine, noting that its effectiveness is somewhat higher.
SOURCE:
.
Source From: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.